Neuronal IL-34 programs microglial activity via the TGF-β–MEF2C axis to constrain neuroinflammation following brain ischemia

Brain ischemia induces robust neuroinflammation driven by microglial activation, yet whether ischemic neurons actively reprogram microglial phenotypes to limit inflammation remains elusive. Here, we identify neuronal interleukin-34 (IL-34) as a critical immunomodulatory signal that maintains microglial homeostasis after cerebral ischemia. We demonstrate that ischemic injury augments IL-34-CSF1R signaling between neurons and microglia. Neuron-specific overexpression of Il34 (Syn1- Il34 tg mice) attenuated infarct volume and neurodeficits after middle cerebral artery occlusion, whereas neuronal Il34 knockdown exacerbated brain injury. Microglial depletion abolished IL-34-mediated neuroprotection, suggesting microglia as essential effectors. Single-cell RNA sequencing revealed that neuronal IL-34 preserved homeostatic microglial signatures ( P2ry12, Cx3cr1, Tgfbr1 ), while suppressing inflammatory activities ( Il1b, Tnf, Cxcl2 ) through upregulation of the transcription factor MEF2C. Mechanistically, IL-34 activated TGF-β signaling in microglia and inhibition of TGF-β signaling abolished the protective effects of IL-34, whereas microglia-specific Mef2c overexpression rescued neuroprotection despite TGF-β blockade. Thus, ischemic neurons deploy IL-34 to orchestrate the immunoregulatory activity of microglia via the TGF-β–MEF2C axis, representing a previously unrecognized endogenous mechanism counteracting neuroinflammation. Our study reveals neuronal IL-34 as a potential therapeutic target for ischemic stroke.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-18
DOI
https://doi.org/10.1073/pnas.2613902123
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neuronal IL-34 programs microglial activity via the TGF-β–MEF2C axis to constrain neuroinflammation following brain ischemia

Caiyun Qi, Tingyu Yin, Hanchen Liu, Jie Zhou et al.
1 links
Proceedings of the National Academy of Sciences
Neuroinflammation and Neurodegeneration Mechanisms
article

Neuronal IL-34 programs microglial activity via the TGF-β–MEF2C axis to constrain neuroinflammation following brain ischemia

Caiyun Qi, Tingyu Yin, Hanchen Liu, Jie Zhou, De‐Cai Tian, Qiang Liu, Xiaochun Chen, Tao Yan, Yali Han, Wenjun Zhang, Ran Li, Minshu Li, Sarah Wu, Yan Pan, Xu Zhou
article en

Abstract

Brain ischemia induces robust neuroinflammation driven by microglial activation, yet whether ischemic neurons actively reprogram microglial phenotypes to limit inflammation remains elusive. Here, we identify neuronal interleukin-34 (IL-34) as a critical immunomodulatory signal that maintains microglial homeostasis after cerebral ischemia. We demonstrate that ischemic injury augments IL-34-CSF1R signaling between neurons and microglia. Neuron-specific overexpression of Il34 (Syn1- Il34 tg mice) attenuated infarct volume and neurodeficits after middle cerebral artery occlusion, whereas neuronal Il34 knockdown exacerbated brain injury. Microglial depletion abolished IL-34-mediated neuroprotection, suggesting microglia as essential effectors. Single-cell RNA sequencing revealed that neuronal IL-34 preserved homeostatic microglial signatures ( P2ry12, Cx3cr1, Tgfbr1 ), while suppressing inflammatory activities ( Il1b, Tnf, Cxcl2 ) through upregulation of the transcription factor MEF2C. Mechanistically, IL-34 activated TGF-β signaling in microglia and inhibition of TGF-β signaling abolished the protective effects of IL-34, whereas microglia-specific Mef2c overexpression rescued neuroprotection despite TGF-β blockade. Thus, ischemic neurons deploy IL-34 to orchestrate the immunoregulatory activity of microglia via the TGF-β–MEF2C axis, representing a previously unrecognized endogenous mechanism counteracting neuroinflammation. Our study reveals neuronal IL-34 as a potential therapeutic target for ischemic stroke.

Proceedings of the National Academy of SciencesVol. 123(47)
Fujian Medical University (CN), Capital Medical University (CN), Tianjin Medical University General Hospital (CN), Beijing Tian Tan Hospital (CN), Union Hospital (CN), Tianjin Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon